The Central Government has notified two landmark amendments to India’s drug regulatory framework. The dual updates—notified by the Ministry of Chemicals and Fertilizers and the Ministry of Health and Family Welfare
Supply Chain Disruptions Threaten Paracetamol, Metformin and Other Essentials
March 18, 2026: The ongoing conflict in Iran is sending shockwaves through India’s pharmaceutical sector, affecting...
